Xin Tai Medical (02291) announced that its Supervisory Board has recommended the appointment of Wang Yong as Supervisor and Chairman of the second-term Supervisory Board. This nomination follows standard corporate governance procedures for board succession planning. The proposed leadership transition demonstrates the company's commitment to maintaining robust oversight structures while ensuring continuity in governance functions. Wang Yong's expected dual role as both Supervisor and Chairman would consolidate board leadership responsibilities under a single executive.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.